Cargando…

The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer

PURPOSE: To analyze how Proclarix is valuable to appropriately select candidates for multiparametric magnetic resonance imaging (mpMRI) and derived biopsies, among men with suspected prostate cancer (PCa). Proclarix is a new marker computing the clinically significant PCa (csPCa) risk, based on seru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morote, Juan, Campistol, Miriam, Celma, Anna, Regis, Lucas, de Torres, Inés, Semidey, María E., Roche, Sarai, Mast, Richard, Santamaría, Anna, Planas, Jacques, Trilla, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Sexual Medicine and Andrology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987145/ https://www.ncbi.nlm.nih.gov/pubmed/35021312 http://dx.doi.org/10.5534/wjmh.210117

Ejemplares similares

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
por: Campistol, Miriam, et al.
Publicado: (2022)

Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category
por: Morote, Juan, et al.
Publicado: (2022)

Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
por: Morote, Juan, et al.
Publicado: (2022)

Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)

Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review
por: Triquell, Marina, et al.
Publicado: (2022)

Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review
por: Cuadras, Mercè, et al.
Publicado: (2022)

The Barcelona Predictive Model of Clinically Significant Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)

A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand
por: Morote, Juan, et al.
Publicado: (2022)

Serum Luteinizing Hormone Testing Can Identify Optimal Medical Castration
por: Morote, Juan, et al.
Publicado: (2020)

Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy
por: Triquell, Marina, et al.
Publicado: (2022)

Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients
por: Morote, Juan, et al.
Publicado: (2017)

The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy
por: Morote, Juan, et al.
Publicado: (2022)

Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate‐specific antigen, digital rectal examination and the prostate‐specific antigen density based on digital rectal prostate volume category
por: Morote, Juan, et al.
Publicado: (2022)

Definition of Castrate Resistant Prostate Cancer: New Insights
por: Morote, Juan, et al.
Publicado: (2022)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
por: Morote, Juan, et al.
Publicado: (2014)

Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2023)

A Systematic Review of the Current Status of Magnetic Resonance–Ultrasound Images Fusion Software Platforms for Transperineal Prostate Biopsies
por: Paesano, Nahuel, et al.
Publicado: (2023)

Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
por: Olivan, M., et al.
Publicado: (2015)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic Biopsies
por: Morote, Juan, et al.
Publicado: (2023)

Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer
por: Luan, Yang, et al.
Publicado: (2022)

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples
por: Olivan, Mireia, et al.
Publicado: (2021)

Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review
por: Aguilar, Adriana, et al.
Publicado: (2023)

Inflammatory changes in biopsy specimens from patients with suspected prostate cancer
por: Adamczyk, Przemysław, et al.
Publicado: (2013)

Identification, characterization and expression of novel Sex Hormone Binding Globulin alternative first exons in the human prostate
por: Pinós, Tomàs, et al.
Publicado: (2009)

Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
por: Willis, Sarah R, et al.
Publicado: (2014)

Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies
por: Sheikh, Nissar, et al.
Publicado: (2016)

Multicentre clinical evaluation of the safety and performance of a simple transperineal access system for prostate biopsies for suspected prostate cancer: The CAMbridge PROstate Biopsy DevicE (CamPROBE) study
por: Gnanapragasam, Vincent J, et al.
Publicado: (2020)

The Present and Future of Prostate Cancer Urine Biomarkers
por: Rigau, Marina, et al.
Publicado: (2013)

Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
por: Cánovas, Verónica, et al.
Publicado: (2017)

Diagnostic accuracy and clinical utility of micro-ultrasound guided biopsies in patients with suspected prostate cancer
por: Dias, Nuno, et al.
Publicado: (2023)

The use of prostate MR for targeting prostate biopsies
por: Kelley, R. Phelps, et al.
Publicado: (2019)

Biopsy interpretation of the prostate
por: Epstein, Jonathan I.

Prostate biopsy interpretation
por: Epstein, Jonathan I.

Bladder Cancer in an Inguinoscrotal Vesical Hernia
por: Regis, Lucas, et al.
Publicado: (2012)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

A risk‐organised model for clinically significant prostate cancer early detection
por: Morote, Juan, et al.
Publicado: (2023)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
por: Balaban, Muhsin, et al.
Publicado: (2020)

Acceptance of female urologists among patients with suspected prostate disease
por: Steinkohl, Fabian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m8p2elee1hco9ad3m100o48k52